San Francisco, March 7, 2011 A ground-breaking pair of scientific meetings, the Joint Summits on Translational Science, open today with several hundred scientists, researchers, academic leaders, and nonprofit and corporate leaders in biomedicine who share a common interest in transforming biomedical research discoveries into clinical treatments and health promotion. AMIA, the association for informatics professionals, convenes the week-long Joint Summits on Translational Bioinformatics (TBI) and Clinical Research Informatics (CRI) to meet the knowledge-driven needs of translational scientists who use the Summits as a key venue in which to share the spectrum of their work in discovery-driven science from 'bench to bedside', find collaborative partners, and network with peers also interested in bridging innovation in biomedical research to patient care.
"AMIA's commitment to TBI and CRI is fundamental to its mission of bridging knowledge and collaboration across a continuum, from basic and applied research to public health and consumer areas," says Edward H. Shortliffe, MD, PhD, FACMI, president and CEO of AMIA. "The Joint Summits provide a unique opportunity for researchers in translational science to come together in a single venue, and to span the full range of informatics applications from basic human biology to clinical care."
"This meeting provides a unique opportunity to bring together the finest minds in TBI and CRI," says TBI Summit Chair Indra Neil Sarkar, PhD, MLIS, director of biomedical informatics and assistant professor at the University of Vermont's Center for Clinical and Translational Science. "The TBI Summit, now in its fourth year, has embraced the trans-disciplinary nature of translational bioinformatics to become the foremost forum for scientific pioneers in biology and health care."
TBI content at the Summit is broken down into four tracks: informatics concepts, tools and techniques to enable integrative transl
|Contact: Nancy Light|
American Medical Informatics Association